These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 424247)
1. [Development of tumorous transplants in mice with induced tumors depending on the activity of the immunological system of the body]. Neĭman IM; Kozlova IN Patol Fiziol Eksp Ter; 1979; (1):61-3. PubMed ID: 424247 [No Abstract] [Full Text] [Related]
3. [Development of drug-induced tumors in mice depending on the activity of the immunocompetent systems of the body]. Neĭman IM; Finogenova MA Patol Fiziol Eksp Ter; 1978; (2):26-9. PubMed ID: 673472 [No Abstract] [Full Text] [Related]
4. [Influence of the tumor process induced by 3-methylcholanthrene and benz(A)pyrene on the development of sarcoma 180 transplants]. Kozlova IN Patol Fiziol Eksp Ter; 1975; (3):77-9. PubMed ID: 1226327 [No Abstract] [Full Text] [Related]
5. [Immunity in transplantation of rat ascitic tumors in mice]. Novikov DK; Adamenko GP; Novikova VI Vopr Onkol; 1972; 18(7):77-81. PubMed ID: 4342629 [No Abstract] [Full Text] [Related]
6. Failure of long-term immunologic control of 3-methylcholanthrene-induced skin tumors in the autochthonous host. Lappé MA J Reticuloendothel Soc; 1971 Jul; 10(1):120-30. PubMed ID: 5121176 [No Abstract] [Full Text] [Related]
7. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice. Wagner JL; Haughton G J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191 [No Abstract] [Full Text] [Related]
8. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma]. Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833 [No Abstract] [Full Text] [Related]
9. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells. Klein E; Klein G Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988 [No Abstract] [Full Text] [Related]
10. [Comparative analysis of the malignancy of tumors in mice induced by 20-methylcholanthrene]. Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA Eksp Onkol; 1985; 7(5):21-4. PubMed ID: 4065015 [TBL] [Abstract][Full Text] [Related]
11. Neonatal thymectomy and tumor induction with methylcholanthrene in mice. Balner H; Dersjant H J Natl Cancer Inst; 1966 Mar; 36(3):513-21. PubMed ID: 18630325 [TBL] [Abstract][Full Text] [Related]
12. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response]. Spasokukotskiĭ AL Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565 [TBL] [Abstract][Full Text] [Related]
13. [Specific growth rate and macrophagal infiltration of experimental tumors]. Kharatseius DA; Montsevichiute-Eringene EV Eksp Onkol; 1985; 7(5):45-7. PubMed ID: 4065019 [TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice]. Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287 [TBL] [Abstract][Full Text] [Related]
15. Experimental radiation therapy and apparent radioresistance of autochthonous tumors subcutaneously induced with 3-methylcholanthrene in mice. Tanooka H; Hoshino H; Tanaka K; Nagase M Cancer Res; 1980 Jul; 40(7):2547-51. PubMed ID: 7388810 [TBL] [Abstract][Full Text] [Related]
16. [Acid phosphatase activity and phagocytic capabilities of reticuloendothelial system cells of mice with experimental tumors]. Durnova GN Biull Eksp Biol Med; 1968 Apr; 65(4):85-7. PubMed ID: 5758481 [No Abstract] [Full Text] [Related]
17. [Study of a transplantable epidermoid epithelioma of the skin of the C3H mouse]. Minet P; Lennes G; Smoliar V C R Seances Soc Biol Fil; 1970; 164(1):193-8. PubMed ID: 4248032 [No Abstract] [Full Text] [Related]
18. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors. Halliday WJ; Koppi TA; McKenzie IF J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199 [TBL] [Abstract][Full Text] [Related]